Zevra Therapeutics ZVRA
NASDAQ ZVRA
$9.99 -0.19 (-1.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Price to Earnings (2025 - 2026)

Updated

Zevra Therapeutics' Price to Earnings was 14.61 in Q2 2026, down 92.0% from 183.54 a year earlier but up 229.3% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Price to Earnings (2025 - 2026) Analysis & Trends

For FY2025, Price to Earnings at Zevra Therapeutics came in at 6.12.

  • Quarterly Price to Earnings has moved between 4.44 (Q1 2026) and 183.54 (Q2 2025) over five years.
  • Per Business Quant data, ZVRA's Price to Earnings in the three quarters before Q2 2026 was 4.44 (Q1 2026), 6.12 (Q4 2025) and 15.13 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Zevra Therapeutics 592.83 Mn -219.88 Mn 38.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.61
Mar 31, 2026 4.44
Dec 31, 2025 6.12
Sep 30, 2025 15.13
Jun 30, 2025 183.54
API Access

Zevra Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ZVRA&period=max&api_key=YOUR_API_KEY